Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 365

1.

Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.

Grah JJ, Katalinic D, Juretic A, Santek F, Samarzija M.

Tumori. 2014 Jan-Feb;100(1):60-8. doi: 10.1700/1430.15817.

PMID:
24675493
2.
3.

Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study.

Matković B, Juretić A, Spagnoli GC, Separović V, Gamulin M, Separović R, Sarić N, Basić-Koretić M, Novosel I, Kruslin B.

Croat Med J. 2011 Apr 15;52(2):171-7.

4.

Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration.

Kim SH, Lee S, Lee CH, Lee MK, Kim YD, Shin DH, Choi KU, Kim JY, Park DY, Sol MY.

Lung. 2009 Nov-Dec;187(6):401-11. doi: 10.1007/s00408-009-9181-3. Epub 2009 Oct 1.

PMID:
19795170
5.

Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.

Shigematsu Y, Hanagiri T, Shiota H, Kuroda K, Baba T, Mizukami M, So T, Ichiki Y, Yasuda M, So T, Takenoyama M, Yasumoto K.

Lung Cancer. 2010 Apr;68(1):105-10. doi: 10.1016/j.lungcan.2009.05.010. Epub 2009 Jul 9.

PMID:
19545928
6.

Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.

Yoshida N, Abe H, Ohkuri T, Wakita D, Sato M, Noguchi D, Miyamoto M, Morikawa T, Kondo S, Ikeda H, Nishimura T.

Int J Oncol. 2006 May;28(5):1089-98.

PMID:
16596224
7.

Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.

Demirović A, Džombeta T, Tomas D, Spajić B, Pavić I, Hudolin T, Milošević M, Cupić H, Krušlin B.

Pathol Res Pract. 2010 Oct 15;206(10):695-9. doi: 10.1016/j.prp.2010.05.013. Epub 2010 Jun 29.

PMID:
20591578
8.

Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.

Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski HR, Heberer M, Spagnoli GC.

Int J Cancer. 2007 Jan 15;120(2):337-43.

9.

Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.

Croat Med J. 2006 Feb;47(1):32-41.

10.

MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma.

Bujas T, Marusic Z, Peric Balja M, Mijic A, Kruslin B, Tomas D.

Eur J Histochem. 2011 Mar 21;55(1):e7. doi: 10.4081/ejh.2011.e7.

11.

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.

Gjerstorff MF, Pøhl M, Olsen KE, Ditzel HJ.

BMC Cancer. 2013 Oct 8;13:466. doi: 10.1186/1471-2407-13-466.

12.

Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.

Su C, Xu Y, Li X, Ren S, Zhao C, Hou L, Ye Z, Zhou C.

Int J Clin Exp Pathol. 2015 May 1;8(5):5509-18. eCollection 2015.

13.

Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.

Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA.

Cancer Res. 2002 Jul 15;62(14):3971-9.

14.

Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis.

Hudolin T, Juretic A, Pasini J, Tomas D, Spagnoli GC, Heberer M, Dimanovski J, Kruslin B.

Urology. 2006 Jul;68(1):205-7. Epub 2006 Jun 27.

PMID:
16806422
15.

Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma.

Sarcevic B, Spagnoli GC, Terracciano L, Schultz-Thater E, Heberer M, Gamulin M, Krajina Z, Oresic T, Separovic R, Juretic A.

Oncology. 2003;64(4):443-9.

PMID:
12759544
16.

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer.

Gure AO, Chua R, Williamson B, Gonen M, Ferrera CA, Gnjatic S, Ritter G, Simpson AJ, Chen YT, Old LJ, Altorki NK.

Clin Cancer Res. 2005 Nov 15;11(22):8055-62.

17.

Analysis of MAT3 gene expression in NSCLC.

Zheng S, Du Y, Chu H, Chen X, Li P, Wang Y, Ma Y, Wang H, Zang W, Zhang G, Zhao G.

Diagn Pathol. 2013 Oct 9;8:166. doi: 10.1186/1746-1596-8-166.

18.

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

John T, Starmans MH, Chen YT, Russell PA, Barnett SA, White SC, Mitchell PL, Walkiewicz M, Azad A, Lambin P, Tsao MS, Deb S, Altorki N, Wright G, Knight S, Boutros PC, Cebon JS.

PLoS One. 2013 Jul 23;8(7):e67876. doi: 10.1371/journal.pone.0067876. Print 2013.

19.

Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.

Bolli M, Kocher T, Adamina M, Guller U, Dalquen P, Haas P, Mirlacher M, Gambazzi F, Harder F, Heberer M, Sauter G, Spagnoli GC.

Ann Surg. 2002 Dec;236(6):785-93; discussion 793.

20.

Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.

Dhodapkar MV, Osman K, Teruya-Feldstein J, Filippa D, Hedvat CV, Iversen K, Kolb D, Geller MD, Hassoun H, Kewalramani T, Comenzo RL, Coplan K, Chen YT, Jungbluth AA.

Cancer Immun. 2003 Jul 23;3:9.

Supplemental Content

Support Center